Skip to main content
Erschienen in: European Radiology 1/2010

01.01.2010 | Gastrointestinal

Evaluation of the effects of oral water and low-density barium sulphate suspension on bowel appearance on FDG-PET/CT

verfasst von: Michael A. Blake, Bindu N. Setty, Carmel G. Cronin, Mannudeep Kalra, Nagaraj Setty Holalkere, Alan J. Fischman, Peter R. Mueller, Dushyant V. Sahani

Erschienen in: European Radiology | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study is to assess which of five bowel preparation regimes offers superior bowel distension and to assess if these regimes adversely affect FDG activity on PET/CT imaging. The study conformed to HIPAA regulations. Ninety patients were divided into five groups of 18 who received no oral contrast agent (group A); 900 ml of water orally (group B); or 900, 1,350, or 1,800 ml of LDB (groups C, D, E, respectively). PET/CT examinations were assessed quantitatively (bowel diameter, SUV) and qualitatively (visual assessment grading scale) for bowel distension and FDG activity by two blinded readers. ANOVA was utilized to determine if a statistically significant difference (SSD) existed between the groups in terms of distension and FDG uptake. Qualitatively superior bowel distension was observed in group C (LDB) compared to B (water) and greater distension was noted with increased volumes of LDB in C, D, and E. Quantitatively there was an SSD in mean distension between groups C and B (P < 0.001 except duodenum). Qualitatively and quantitatively there was no significant difference in bowel FDG uptake among the groups (P > 0.05). LDB as an oral contrast agent provides superior bowel distension over water and does not induce increased FDG bowel activity.
Literatur
1.
Zurück zum Zitat Dizendorf EV, Treyer V, Von Schulthess GK et al (2002) Application of oral contrast media in coregistered positron emission tomography-CT. AJR Am J Roentgenol 179:477–481PubMed Dizendorf EV, Treyer V, Von Schulthess GK et al (2002) Application of oral contrast media in coregistered positron emission tomography-CT. AJR Am J Roentgenol 179:477–481PubMed
2.
Zurück zum Zitat Kluetz PG, Meltzer CC, Villemagne VL et al (2000) Combined PET/CT imaging in oncology. Impact on patient management. Clin Positron Imaging 3:223–230CrossRefPubMed Kluetz PG, Meltzer CC, Villemagne VL et al (2000) Combined PET/CT imaging in oncology. Impact on patient management. Clin Positron Imaging 3:223–230CrossRefPubMed
3.
Zurück zum Zitat Faulhaber P, Nelson A, Mehta L et al (2000) The fusion of anatomic and physiologic tomographic images to enhance accurate interpretation. Clin Positron Imaging 3:178CrossRefPubMed Faulhaber P, Nelson A, Mehta L et al (2000) The fusion of anatomic and physiologic tomographic images to enhance accurate interpretation. Clin Positron Imaging 3:178CrossRefPubMed
4.
Zurück zum Zitat Antoch G, Freudenberg LS, Stattaus J et al (2002) Whole-body positron emission tomography-CT: optimized CT using oral and IV contrast materials. AJR Am J Roentgenol 179:1555–1560PubMed Antoch G, Freudenberg LS, Stattaus J et al (2002) Whole-body positron emission tomography-CT: optimized CT using oral and IV contrast materials. AJR Am J Roentgenol 179:1555–1560PubMed
5.
Zurück zum Zitat Hamm B (1992) Contrast materials for cross-sectional imaging of the abdomen. Curr Opin Radiol 4:93–104PubMed Hamm B (1992) Contrast materials for cross-sectional imaging of the abdomen. Curr Opin Radiol 4:93–104PubMed
6.
Zurück zum Zitat Gore R (1994) Cross-sectional imaging of colon. In: Gore R, Levine MS, Laufer I (eds) Textbook of gastrointestinal radiology. W.B. Saunders, Philadelphia, pp 1051–1063 Gore R (1994) Cross-sectional imaging of colon. In: Gore R, Levine MS, Laufer I (eds) Textbook of gastrointestinal radiology. W.B. Saunders, Philadelphia, pp 1051–1063
7.
Zurück zum Zitat Antoch G, Kuehl H, Kanja J et al (2004) Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluation. Radiology 230:879–885CrossRefPubMed Antoch G, Kuehl H, Kanja J et al (2004) Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluation. Radiology 230:879–885CrossRefPubMed
8.
Zurück zum Zitat Cohade C, Osman M, Nakamoto Y et al (2003) Initial experience with oral contrast in PET/CT: phantom and clinical studies. J Nucl Med 44:412–416PubMed Cohade C, Osman M, Nakamoto Y et al (2003) Initial experience with oral contrast in PET/CT: phantom and clinical studies. J Nucl Med 44:412–416PubMed
9.
Zurück zum Zitat Antoch G, Jentzen W, Freudenberg LS et al (2003) Effect of oral contrast agents on computed tomography-based positron emission tomography attenuation correction in dual-modality positron emission tomography/computed tomography imaging. Invest Radiol 38:784–789PubMed Antoch G, Jentzen W, Freudenberg LS et al (2003) Effect of oral contrast agents on computed tomography-based positron emission tomography attenuation correction in dual-modality positron emission tomography/computed tomography imaging. Invest Radiol 38:784–789PubMed
10.
Zurück zum Zitat Groves AM, Kayani I, Dickson JC et al (2005) Oral contrast medium in PET/CT: should you or shouldn’t you? Eur J Nucl Med Mol Imaging 32:1160–1166CrossRefPubMed Groves AM, Kayani I, Dickson JC et al (2005) Oral contrast medium in PET/CT: should you or shouldn’t you? Eur J Nucl Med Mol Imaging 32:1160–1166CrossRefPubMed
11.
Zurück zum Zitat Gutman F, Alberini JL, Wartski M et al (2005) Incidental colonic focal lesions detected by FDG PET/CT. AJR Am J Roentgenol 185:495–500CrossRefPubMed Gutman F, Alberini JL, Wartski M et al (2005) Incidental colonic focal lesions detected by FDG PET/CT. AJR Am J Roentgenol 185:495–500CrossRefPubMed
12.
Zurück zum Zitat Otsuka H, Graham MM, Kubo A et al (2005) The effect of oral contrast on large bowel activity in FDG-PET/CT. Ann Nucl Med 19:101–108CrossRefPubMed Otsuka H, Graham MM, Kubo A et al (2005) The effect of oral contrast on large bowel activity in FDG-PET/CT. Ann Nucl Med 19:101–108CrossRefPubMed
13.
Zurück zum Zitat Megibow AJ, Babb JS, Hecht EM et al (2006) Evaluation of bowel distention and bowel wall appearance by using neutral oral contrast agent for multi-detector row CT. Radiology 238:87–95CrossRefPubMed Megibow AJ, Babb JS, Hecht EM et al (2006) Evaluation of bowel distention and bowel wall appearance by using neutral oral contrast agent for multi-detector row CT. Radiology 238:87–95CrossRefPubMed
14.
Zurück zum Zitat Thompson SE, Raptopoulos V, Sheiman RL et al (1999) Abdominal helical CT: milk as a low-attenuation oral contrast agent. Radiology 211:870–875PubMed Thompson SE, Raptopoulos V, Sheiman RL et al (1999) Abdominal helical CT: milk as a low-attenuation oral contrast agent. Radiology 211:870–875PubMed
15.
Zurück zum Zitat Hebert JJ, Taylor AJ, Winter TC et al (2006) Low-attenuation oral GI contrast agents in abdominal-pelvic computed tomography. Abdom Imaging 31:48–53CrossRefPubMed Hebert JJ, Taylor AJ, Winter TC et al (2006) Low-attenuation oral GI contrast agents in abdominal-pelvic computed tomography. Abdom Imaging 31:48–53CrossRefPubMed
16.
Zurück zum Zitat Winter TC, Ager JD, Nghiem HV et al (1996) Upper gastrointestinal tract and abdomen: water as an orally administered contrast agent for helical CT. Radiology 201:365–370PubMed Winter TC, Ager JD, Nghiem HV et al (1996) Upper gastrointestinal tract and abdomen: water as an orally administered contrast agent for helical CT. Radiology 201:365–370PubMed
17.
Zurück zum Zitat Sahani DV, Jhaveri KS, D’Souza R V et al (2003) Evaluation of simethicone-coated cellulose as a negative oral contrast agent for abdominal CT. Acad Radiol 10:491–496CrossRefPubMed Sahani DV, Jhaveri KS, D’Souza R V et al (2003) Evaluation of simethicone-coated cellulose as a negative oral contrast agent for abdominal CT. Acad Radiol 10:491–496CrossRefPubMed
18.
Zurück zum Zitat Drenth JP, Nagengast FM, Oyen WJ (2001) Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings. Eur J Nucl Med 28:1766–1769CrossRefPubMed Drenth JP, Nagengast FM, Oyen WJ (2001) Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings. Eur J Nucl Med 28:1766–1769CrossRefPubMed
19.
Zurück zum Zitat Hausegger K, Reinprecht P, Kau T et al (2005) Clinical experience with a commercially available negative oral contrast medium in PET/CT. Rofo 177:796–799PubMed Hausegger K, Reinprecht P, Kau T et al (2005) Clinical experience with a commercially available negative oral contrast medium in PET/CT. Rofo 177:796–799PubMed
20.
Zurück zum Zitat Agress H Jr, Cooper BZ (2004) Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison. Radiology 230:417–422CrossRefPubMed Agress H Jr, Cooper BZ (2004) Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison. Radiology 230:417–422CrossRefPubMed
21.
Zurück zum Zitat Al Hawary MM, Platt J, Francis I (2005) Comparison of adequacy of oral contrast bowel preparation with two different low attenuation agents for CT enterography (CTE) in patients with known or suspected inflammatory bowel disease (abstract). In: Radiological Society of North America scientific assembly and annual meeting program. Radiological Society of North America, Oak Brook, IL Al Hawary MM, Platt J, Francis I (2005) Comparison of adequacy of oral contrast bowel preparation with two different low attenuation agents for CT enterography (CTE) in patients with known or suspected inflammatory bowel disease (abstract). In: Radiological Society of North America scientific assembly and annual meeting program. Radiological Society of North America, Oak Brook, IL
22.
Zurück zum Zitat Otsuka H, Graham MM, Kubo A et al (2005) The effect of oral contrast on large bowel activity in FDG-PET/CT. Ann Nucl Med 19:101–108CrossRefPubMed Otsuka H, Graham MM, Kubo A et al (2005) The effect of oral contrast on large bowel activity in FDG-PET/CT. Ann Nucl Med 19:101–108CrossRefPubMed
Metadaten
Titel
Evaluation of the effects of oral water and low-density barium sulphate suspension on bowel appearance on FDG-PET/CT
verfasst von
Michael A. Blake
Bindu N. Setty
Carmel G. Cronin
Mannudeep Kalra
Nagaraj Setty Holalkere
Alan J. Fischman
Peter R. Mueller
Dushyant V. Sahani
Publikationsdatum
01.01.2010
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 1/2010
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-009-1527-y

Weitere Artikel der Ausgabe 1/2010

European Radiology 1/2010 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.